Some older people with diabetes may have reduced endogenous insulin secretory capacity owing to age or other reasons [19], and treatment with LIs plus RIs or LIs plus diabetes drugs other than insulin is thus often selected. This evidence concerns the gene INS and diabetes mellitus.